Increased plasma and hepatic TNF-activity has been implicated in the pathogenesis of alcoholic liver disease. We previously reported that monocytes from alcoholic patients 
INTRODUCTION
Inflammatory cytokines, particularly TNF-, plays a significant role in the pathogenesis of liver injury and the clinical/biochemical abnormalities of alcoholic hepatitis (AH) (12, (22) (23) (24) . We first reported dysregulated TNF metabolism in AH over 15 years ago with the observation that cultured monocytes (which produce the overwhelming majority of systemic circulating TNF and are a surrogate marker for Kupffer cells) from AH patients spontaneously produced TNF and produced significantly more TNF in response to an LPS stimulus (22) . Further, we and others have shown that there are increased serum levels of TNF, increased monocyte TNF production, and hepatic immunohistochemical staining for TNF in AH that frequently correlate with disease severity and mortality (3, 8, 16, 18, 21, 22, 24, 30) . Circulating monocytes play an important role in the response to inflammatory agents, particularly to agents entering the circulation that are derived from gut bacteria, such as bacterial endotoxin. This is relevant since patients with AH commonly have endotoxemia (2, 4, 5, 30) . LPS is a potent stimulus for monocyte TNF production, and LPS activates the oxidative stress-sensitive transcription factor NF-B, which modulates the synthesis of several adhesion molecules and inflammatory cytokines including TNF (10, 26, 39) . Concomitant with these human findings , studies in rats, mice, and cultured cells evaluated the role of cytokines (especially TNF) in experimental models of liver disease (21) . Perhaps the most compelling data documenting the critical role of TNF in the development of alcoholic liver disease (ALD) is provided by the experiments which successfully used anti-TNF antibody to prevent liver injury in alcohol fed rats (14) and the observation that mice lacking the TNF-type I receptor do not develop alcoholic liver injury (40) .
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Although the role of TNF as a critical inflammatory cytokine in the progression of ALD has been well established, the mechanism by which ethanol enhances TNF expression, particularly in monocytes/macrophages, is only beginning to be understood (17, 41, 43) . Increases in cellular cAMP levels by different types of cAMP enhancers has invariably been found to result in the suppression of TNF production stimulated either in vitro or in vivo with LPS in monocytes/macrophages of both human and murine origin (44). Various studies have documented that depending on the cell type, suppression of LPS-inducible TNF production by cAMP can occur in both NF-B dependent as well as independent mechanisms (28, 31, 33, 36, 38) . In relation to the effects of chronic ethanol exposure, it has been observed that lymphocytes from alcoholics in comparison to nonalcoholics have greatly diminished levels of both basal and receptor-stimulated cAMP levels (6, 27) . Although, cAMP is the most widely known second messenger that downregulates TNF production, its role in the ethanol mediated enhancement of LPS-inducible TNF production by monocytes/macrophages has not been investigated. It is also not known whether elevation of cellular cAMP in monocytes/macrophages would attenuate/inhibit the synergistic enhancement in TNF-expression caused by ethanol and LPS.
In the present study we assessed the effects of chronic ethanol exposure on monocytes/macrophages in relation to basal and LPS-stimulated cAMP levels and TNF production. Using a non-degradable, cell permeable cAMP analogue (dbcAMP) we further evaluated the effect of increased cellular cAMP levels on LPS-inducible TNF expression in monocytes/macrophages exposed chronically to ethanol. Our data reveal that chronic ethanol exposure leads to a decline in basal and stimulatable cAMP levels G-00098-2006.R1 which play a major role in the enhancement of LPS-inducible TNF production by monocytes/macrophages. Further, an increase in cellular cAMP levels leads to the inhibition of the synergistic enhancement in TNF-expression caused by ethanol and LPS. The attenuation of TNF expression occurs at the transcriptional level and involves inhibition of NF-B activity, the major regulator of TNF transcription in monocytes/macrophages.
MATERIALS AND METHODS
Materials. RAW 264.7 murine monocytes were obtained from the American Type Culture Collection (ATCC, Manassas, VA). LPS (Escherichia coli 0111:B4) was purchased from Difco Laboratories (Detroit, MI). Before use, LPS was dissolved in sterile, pyrogen-free water, sonicated, and diluted with sterilized phosphate-buffered saline (PBS). Penicillin, streptomycin, DMEM media, fetal bovine serum was purchased from Invitrogen (Grand Island, NY); murine TNF-ELISA kit was from BioSource International (Camarillo, CA) and cAMP Immunoassay kit was from R&D Systems, Inc. Animal model. The rat model of alcoholic liver disease we used has been previously described in detail (35). Increased gut permeability leading to enhanced circulating levels of LPS and TNF expression by Kupffer cells in this model is a major cause of liver injury (7, 14, 15 Nonadherent cells were removed 3 h after seeding, and fresh culture medium with 5%
FBS was added and replaced every day until the experiments began. Cells were grown in a humidified 5% CO 2 -37°C atmosphere and were used 2-3 days after seeding.
Cell culture. RAW 264.7 cells were cultured in DMEM containing 10% (vol/vol) fetal bovine serum, 10 U/ml penicillin, and 10 µg/ml streptomycin at 37 0 C in a humidified 5% CO 2 atmosphere. Cells were chronically exposed to 25 mM ethanol for a period of 6 weeks.
Cell proliferation assay. Cell proliferation and viability assay was measured in control as well as ethanol treated cells by a colorimetric assay based on the cleavage of the tetrazolium salt WST-1 by mitochondrial dehydrogenases according to the manufacturer's instructions.
TNF-and cyclic AMP assay. TNF-in conditioned medium and cyclic AMP concentrations in cell lysates were quantified using ELISA kit in accordance with the manufacturer's instructions. All assays were run in triplicate.
RNA isolation and real-time PCR analysis.
RT-PCR assays were used to assess TNF-mRNA levels in RAW 264.7 and Kupffer cells. Total RNA was isolated from cells using TRIZOL (Invitrogen, Carlsbad, CA, USA). For real-time PCR, the first-strand cDNA was synthesized using TaqMan Reverse transcription reagents (Applied Biosystems). The reverse transcription was carried out using 1x Taqman RT buffer, 
Electrophoretic mobility shift assay (EMSA). Double stranded oligonucleotide containing the binding site for NF-B (5'-AGT-TGA-GGG-GAC-TTT-CCC-AGG-C-3',
Promega, Madison, WI) was end-labeled with ( 32 P) dATP using T4 polynucleotide kinase (GibcoBRL, Grand Island, NY). Nuclear proteins (5µg) were incubated in binding buffer (50mM Tris pH 7.5, 500mM NaCl, 5mM DTT, 5mM EDTA, 20%(v/v) glycerol and 0.4mg/ml sonicated salmon sperm DNA) with 0.3ng of 32 P-labeled probe for 20 min.
at room temperature. The resultant DNA/protein complexes were separated by electrophoresis on a 5% nondenaturing polyacrylamide gel in 0.5X TBE (50mM Tris pH 8.0, 45mM borate, 5mM EDTA). The gels were dried and analyzed by autoradiography for ~ 18h. The specificity of the reaction was evaluated by incubating the nuclear extract with a 10 fold molar excess of unlabeled wild type (W) and mutant (M) oligonucleotides.
Western blot analysis. Nuclear proteins (30 µg) were analyzed by SDSpolyacrylamide gel electrophoresis using a Bio-Rad (Hercules, CA) electrophoresis system, followed by immunoblotting according to the manufacturer's instructions.
G-00098-2006.R1
Immunoreactive bands were visualized using the enhanced chemiluminescence light detection reagents (Amersham, Arlington Heights, IL). Luciferase assay. Luciferase activity was measured using Luciferase Assay Reagent (Promega, Madison, WI). After treatments, total cell lysates were prepared in reporter lysis buffer (Promega). Luciferase enzymatic activity was measured in a TD 20/20 Luminometer using a specific substrate provided by Promega.
Plasmids and transfections. NF-B -
Statistical analysis. All experiments were repeated at least three times. Data were presented as means± SD for the indicated number of independently performed experiments. Student's t-test was used for the determination of statistical significance.
P<0.05 was considered significant.
RESULTS

Effect of chronic ethanol exposure on cellular cAMP levels. Chronic ethanol exposure decreases cellular cAMP levels in monocytes: Studies in monocytes have
shown that cAMP plays a significant role in regulating TNF-expression and elevation of cellular cAMP suppresses TNF-production. Hence, the effect of chronic ethanol exposure on the cellular levels of cAMP as well as TNF expression in monocytes was Intracellular cAMP levels were evaluated in cell lysates obtained from monocytes with or without chronic ethanol treatment and subsequent LPS stimulation (100 ng/ml; 3 h). As has been reported earlier, LPS stimulation led to an increase in the intracellular cAMP levels. However, chronic ethanol exposure led to a considerable decrease in cellular cAMP levels in both basal and LPS stimulated monocytes ( Fig. 2A) . We extended these observations to demonstrate a similar effect of chronic ethanol exposure in rat primary hepatic Kupffer cells obtained from a clinically relevant enteral alcohol feeding model of ALD. As compared to the control pair-fed animals, ethanol-fed animals have increased gut permeability and measurable circulating levels of endotoxin.
Consequently, Kupffer cells isolated from these animals are exposed and sensitized to TNF production by ELISA. Although ethanol had a minimal effect on the spontaneous release of TNF, LPS-inducible TNF production was found to be significantly increased in ethanol-treated cells (Fig. 3) . Further, the effect of increased cellular cAMP levels on TNF expression by ethanol treated cells was examined. Enhancement in cellular cAMP levels was achieved by exogenous supplementation of nondegradable cAMP (dbcAMP).
Pretreatment of ethanol treated monocytes with dbcAMP (100 -1000 µM) effectively inhibited the synergistic enhancement in the TNF-expression caused by ethanol and LPS in a dose dependent manner (Fig. 4) .
Effect of chronic alcohol exposure and cellular cAMP levels on LPS-induced TNF gene transcription in monocytes.
To address the mechanism involved in the effects of chronic ethanol exposure and cellular cAMP levels on TNF production, steady state levels of TNF mRNA were quantified. Real time PCR analysis of total RNA obtained from appropriately treated cells showed that the LPS-inducible steady state TNF mRNA G-00098-2006.R1 levels were significantly higher in ethanol treated monocytes as compared to control cells, corroborating our earlier findings and work done by others (Fig. 5) . Further, this synergistic enhancement in the TNF mRNA levels caused by ethanol and LPS was significantly attenuated by dbcAMP at each time point evaluated (Fig. 6) . Also, in correspondence with decreased cellular cAMP levels, and in agreement with earlier reports, hepatic Kupffer cells obtained from rats chronically fed alcohol (which have been exposed to gut-derived LPS) showed a substantial increase (four fold) in the steady state TNF mRNA levels (Fig. 7) . monocytes as well as in monocytes chronically exposed to ethanol (Fig. 8) . Also, the pretreatment with dbcAMP which abolished the enhancement in the LPS-inducible steady state TNF mRNA expression in ethanol treated monocytes, had no effect on the Notably, pretreatment of cells with dbcAMP which effectively inhibited the synergistic enhancement in the TNF-expression caused by ethanol did not decrease the nuclear levels of LPS-inducible p65 (Fig. 9A, lanes 3 and 6) , on the contrary, nuclear p65 levels were slightly increased.
EMSA was performed to assess the effect of ethanol and dbcAMP on NF-B DNA binding to the consensus B sequence. Nuclear extracts were isolated from ethanol treated monocytes without or with dbcAMP followed by LPS treatment. Correspondent to the p65 nuclear levels, dbcAMP did not have any effect on the ethanol and LPS mediated NF-B DNA binding (Fig. 9B) . promoter activity approximately fourfold. dbcAMP pretreatment significantly attenuated the increases in LPS-stimulated NF-B promoter activity (decreased by 43 %) (Fig.10) .
Taken together, these data indicate that cAMP has minimal to no effect on the LPSinducible signaling components leading to NF-B activation, however, it can significantly decrease gene expression mediated by NF-B dependent trans-activation.
Further, the data also suggests that a decrease in LPS-inducible cAMP levels caused by chronic ethanol exposure plays a major role in the priming of monocytes to produce higher levels of TNF-and enhancement of cAMP levels can effectively block this NF- 
